Table 2. Fasting plasma glucose levels before treatment in the control and intervention groups.
| Variable | Indicator | Full analysis set | Per protocol set | |||
|---|---|---|---|---|---|---|
| Intervention group | Control group | Intervention group | Control group | |||
| Baseline | N [missing] | 54 [0] | 59 [1] | 49 [0] | 55 [0] | |
| Mean (SD) | 12.08 (2.80) | 11.97 (3.53) | 11.88 (2.81) | 11.94 (3.59) | ||
| Median | 11.99 | 12.24 | 11.27 | 12.24 | ||
| Q1–Q3 | 9.84–13.71 | 9.30–14.83 | 9.81–13.45 | 9.30–14.83 | ||
| Min–Max | 7.36–21.17 | 4.96–19.77 | 7.36–21.17 | 4.96–19.77 | ||
| P valuea | 0.860 | 0.915 | ||||
| Day 7 | N [missing] | 53 [1] | 59 [1] | 49 [0] | 55 [0] | |
| Mean (SD) | 6.26 (1.67) | 6.06 (1.83) | 6.31 (1.72) | 5.94 (1.81) | ||
| Median | 5.92 | 5.58 | 6.03 | 5.42 | ||
| Q1–Q3 | 5.04–7.24 | 4.75–7.36 | 5.04–7.26 | 4.69–7.21 | ||
| Min–Max | 3.88–12.44 | 3.00–14.01 | 3.88–12.44 | 3.00–14.01 | ||
| P valueb | 0.418 | 0.193 | ||||
a, the comparison was conducted using Student’s t-test; b, the comparison was conducted using the Wilcoxon rank-sum test.